...
首页> 外文期刊>HPB: the official journal of the International Hepato Pancreato Biliary Association >Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations
【24h】

Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations

机译:肝动脉栓塞治疗治疗肝细胞癌:CEPO审查和临床建议

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundHepatocellular carcinoma (HCC) is one of the most deadly cancers in the world and its incidence rate has consistently increased over the past 15 years in Canada. Although transarterial embolization therapies are palliative options commonly used for the treatment of HCC, their efficacy is still controversial. The objective of this guideline is to review the efficacy and safety of transarterial embolization therapies for the treatment of HCC and to develop evidence-based recommendations.
机译:BackgroundHepatocellular癌(HCC)是其中之一世界上最致命的癌症,它发病率一直在增加过去15年在加拿大。肝动脉栓塞治疗缓和的常用选项治疗肝癌,但其疗效仍在有争议的。评估的有效性和安全性肝动脉栓塞治疗治疗肝细胞癌和以证据为基础的发展建议。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号